Background & Aims
Preliminary data suggest that non-invasive methods could be useful to assess presence of oesophageal varices (OV) in cirrhotic patients. We aimed to further investigate simple serum non-invasive markers for diagnosing and grading OV.
A retrospective set of 510 cirrhotics and a prospective set of 110 cirrhotics were enrolled consecutively in five centers. Platelets, AST-to-ALT ratio, AST-to-platelet-ratio index, Forns’ index, Lok index, Fib-4, and Fibroindex were measured within 2 months from upper endoscopy, taken as a gold standard. Performance was expressed as sensitivity, specificity, positive, and negative predictive values (PPV, NPV), accuracy, and area under the curve (AUC).
A combination of Lok index (cutoff = 1.5) and Forns’ index (cutoff = 8.8) had 0.80 AUC (0.76–0.84, 95% CI), and high NPV (>90%) to exclude clinically relevant OV, defined as large OV or small OV with red signs or in Child–Pugh C cirrhosis. By applying this combination, upper endoscopy would have been avoided in 1/3 of our cirrhotics. Large OV could be excluded with 96% NPV by Lok index (cutoff = 1.5). A combination of Lok index (cutoff = 0.9) and Forns’ index (cutoff = 8.5) predicted presence of any grade OV with good performance: 0.82 AUC (0.76–0.88, 95% CI), 88% PPV.
Serum non-invasive markers may be useful as a first line tool to identify cirrhotic patients in which the risk of clinically relevant OV is trivial, and to reduce the number of upper endoscopies. However, we are still far from the possibility of replacing upper endoscopy by simple serum non-invasive markers in the vast majority of patients.
Abbreviations:OV (oesophageal varices), AAR (AST-to-ALT ratio), APRI (AST-to-platelet ratio index), AUC (area under the receiving operating characteristic curve), SD (standard deviation), OR (odds ratio), CI (confidence intervals), PPV (positive predictive value), NPV (negative predictive value), LR (likelihood ratio)
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Hepatology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes.Gastroenterology. 2002; 122: 1620-1630
- Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.Hepatology. 2004; 40: 652-659
- Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.Gastroenterology. 2006; 131: 1611-1624
- Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.J Hepatol. 2005; 43: 167-176
- Non-invasive (and minimally invasive) diagnosis of oesophageal varices.J Hepatol. 2008; 49: 520-527
- Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.J Hepatol. 1992; 15: 256-261
- Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.Arch Intern Med. 2003; 163: 218-224
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Hepatology. 2003; 38: 518-526
- Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.Hepatology. 2002; 36: 986-992
- Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.Hepatology. 2005; 42: 282-292
- FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest.Hepatology. 2007; 46: 32-36
- Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.Hepatology. 2007; 45: 297-306
- Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.Gastroenterology. 2005; 128: 343-350
- Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.Biometrics. 1988; 44: 837-845
- The meaning and use of the area under a receiving operating characteristic (ROC) curve.Radiology. 1982; 143: 29-36
- Portal hypertension and its complications.Gastroenterology. 2008; 134: 1715-1728
- Changing compliance to the American College of Gastroenterology guidelines for the management of variceal hemorrhage: a regional survey.Am J Gastroenterol. 2004; 99: 645-649
- SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.Hepatology. 2009; 49: 1821-1827
- Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.J Hepatol. 2009; 50: 59-68
- Prediction of esophageal varices in patients with cirrhosis.J Clin Gastroenterol. 2002; 34: 81-85
- The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.Gastrointest Endosc. 2006; 64: 855-864
- Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis.Hepatology. 2008; 47: 153-159
- MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.Lancet. 2001; 357: 1069-1075
- Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.Liver Int. 2006; 26: 271-278
- Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.Hepatology. 2007; 45: 1290-1297
- Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis.Gut. 2003; 52: 1200-1205
- Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study.Am J Gastroenterol. 2006; 101: 2511-2519
Published online: June 16, 2010
Accepted: April 6, 2010
Received in revised form: April 4, 2010
Received: October 6, 2009
© 2010 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.